Literature DB >> 16733267

Perspectives: an international review of the national cost estimates of mental illness, 1990-2003.

Teh-wei Hu1.   

Abstract

BACKGROUND: Mental illness is a major group of disorder that can lead to both physical and emotional disability. Policymakers need to learn not only the epidemiological indicators of mental illness, such as prevalence rate and incidence rate, but also the size of its negative impact on the economy. AIMS OF THE STUDY: This study is to review international publications on cost of major mental illness literature, from 1990 to 2003, focusing on the concepts, methods, and future perspective of cost illness studies. Reviewing the status quo on costs of mental illness can provide further information about gaps, limitations, and future needs on this topic.
METHOD: This review searched all major international journals in psychiatry, clinical psychology, health economics, and mental health policy published since 1990. All national or aggregate cost of mental illness studies were included in the review. All were individually reviewed using a conceptual framework of cost of illness methodology.
RESULTS: A large majority of published cost of mental illness studies were conducted in the US and UK. Cost of illness studies were lacking from Africa, Asia, Eastern Europe, and Latin America. Empirical results from the reviewed studies indicate that the negative economic consequences of mental illness far exceed the direct costs of treatment, thus making it important to treat mental illness. Direct treatment costs for each mental disorder (i.e. depression, schizophrenia, dementia, etc.) is between 1% and 2% of total national health care costs. DISCUSSION: The studies reviewed indicate great variation in cost estimates even for the same mental disorder during the same time period within a country. These wide variations may be due to differences in disorder classification, definition of cost categories, sample populations, data sources, and discounting rate. Given the limitations of the cost of illness studies reviewed, one should be careful in interpreting and using these estimated results. IMPLICATIONS FOR HEALTH SERVICES: These cost studies can be useful for understanding the magnitude of treating an illness of economic consequences or economic consequences of an illness for purposes of planning or budgeting. Such studies are one way to inform policymakers about economic consequences of mental illness.

Entities:  

Mesh:

Year:  2006        PMID: 16733267

Source DB:  PubMed          Journal:  J Ment Health Policy Econ        ISSN: 1099-176X


  28 in total

1.  Mental health services in the health accounts: the Czech Republic.

Authors:  Martin Dlouhy
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-19       Impact factor: 4.328

2.  Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain's economy?

Authors:  Juan Oliva-Moreno
Journal:  Eur J Health Econ       Date:  2011-08-20

3.  Prevalence, Employment Rate, and Cost of Schizophrenia in a High-Income Welfare Society: A Population-Based Study Using Comprehensive Health and Welfare Registers.

Authors:  Stig Evensen; Torbjørn Wisløff; June Ullevoldsæter Lystad; Helen Bull; Torill Ueland; Erik Falkum
Journal:  Schizophr Bull       Date:  2015-10-03       Impact factor: 9.306

4.  Psychotherapies for depression in low- and middle-income countries: a meta-analysis.

Authors:  Pim Cuijpers; Eirini Karyotaki; Mirjam Reijnders; Marianna Purgato; Corrado Barbui
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

Review 5.  Cost of falls in old age: a systematic review.

Authors:  S Heinrich; K Rapp; U Rissmann; C Becker; H-H König
Journal:  Osteoporos Int       Date:  2009-11-19       Impact factor: 4.507

6.  Disability and treatment of psychiatric and physical disorders in South Africa.

Authors:  Sharain Suliman; Dan J Stein; Landon Myer; David R Williams; Soraya Seedat
Journal:  J Nerv Ment Dis       Date:  2010-01       Impact factor: 2.254

7.  Social/economic costs and health-related quality of life in patients with scleroderma in Europe.

Authors:  Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Panos Kanavos; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; Márta Péntek; Claudia Delgado; Johann Mathias von der Schulenburg; Ulf Persson; Karine Chevreul; Giovanni Fattore
Journal:  Eur J Health Econ       Date:  2016-04-02

8.  Individual and societal effects of mental disorders on earnings in the United States: results from the national comorbidity survey replication.

Authors:  Ronald C Kessler; Steven Heeringa; Matthew D Lakoma; Maria Petukhova; Agnes E Rupp; Michael Schoenbaum; Philip S Wang; Alan M Zaslavsky
Journal:  Am J Psychiatry       Date:  2008-05-07       Impact factor: 18.112

Review 9.  Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

Authors:  O D Howes; A Egerton; V Allan; P McGuire; P Stokes; S Kapur
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  Non-specialist health worker interventions for mental health care in low- and middle- income countries.

Authors:  Nadja van Ginneken; Prathap Tharyan; Simon Lewin; Girish N Rao; Renee Romeo; Vikram Patel
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.